Ms. Helen Hovenga Joins Telix as Chief People Officer
August 03, 2021 17:48 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive...
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
July 11, 2021 18:40 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Kyahn Williamson has joined the Telix...
First Patient Dosed in Clinical Study of TLX250-CDx in Bladder Cancer
June 22, 2021 19:22 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that a first patient has been dosed in a Phase I study of...
Telix to Present at the 2021 Jefferies Virtual Healthcare Conference
June 01, 2021 08:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Chief Executive Officer, Dr. Christian...
First Patient Dosed in Japanese Prostate Cancer Imaging Study
May 24, 2021 21:04 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, May 25, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a...
TLX66 Meets Study Objectives in Patients with AL Amyloidosis
May 24, 2021 20:59 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and SOUTHAMPTON, United Kingdom, May 25, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company’s bone marrow...
Telix and Monrol Expand Alliance to Include Lutetium Supply
May 10, 2021 18:57 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and ISTANBUL, Turkey, May 10, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered a global clinical supply...
Telix Commences Phase III Clinical Trial of Prostate Cancer Therapy
May 09, 2021 19:13 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, May 09, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has been granted Human Research Ethics Committee (HREC)...
Telix Pharmaceuticals Appoints Mr. Richard Valeix as EMEA President
May 02, 2021 19:15 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and HERSTAL, Belgium, May 02, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Mr. Richard Valeix has joined the Telix...
El NOBLE Registry – Una colaboración internacional para el desarrollo de imágenes SPECT iPSMA para el cáncer de próstata
April 21, 2021 00:59 ET
|
Telix Pharmaceuticals Limited
BRUSELAS, Bélgica y MELBOURNE, Australia., April 20, 2021 (GLOBE NEWSWIRE) -- La Oncidium Foundation, una organización sin fines de lucro creada para promover y apoyar el desarrollo de...